Thank you, Mr. Chair.
I want to thank the ministers and all the senior officials for being here in committee. It has been a long time since we met in person.
Minister Bennett, I also have several questions for you.
To start, I think there's been some recent confusion regarding politicization of the approaches to addressing the toxic drug crisis, which we know requires an array of responses along a spectrum of prevention, health promotion, harm reduction, access to clinical treatment services, including opioid agonist therapy, other clinical supports, adequate social supports, access to treatment and recovery for those who are ready.
Also, may I mention legislative actions such as those we've accomplished with Bill C-5, which addresses unfair mandatory minimum policies and modernizing drug policy, including, ultimately, decriminalization of personal possession of illicit drugs?
As an MP, I represent the Yukon, which is still struggling in the opioid drug crisis but nevertheless has made some substantial gains in a number of these areas.
My first maybe very quick question is, how much should we rely on values alone versus evidence in determining drug policy or, for that matter, any health policy?